Skip to main content
. 2020 Apr 28;36(7):793–805. doi: 10.1007/s12264-020-00502-w

Fig. 4.

Fig. 4

Inhibition of EZH2 by GSK126 suppresses neuroinflammation and induces autophagy. A, B The 50%MWT (A) and CWS (B) in the Sham and NeuP groups after GSK126 treatment from day 3 to day 14 post-surgery (mean ± SD; n = 8; n.s., no significant difference among Sham, NeuP and GSK126 groups; *P < 0.05, **P < 0.01, ***P < 0.001 vs NeuP group; #P < 0.05, ##P < 0.01 vs Sham group). C, D Relative expression of EZH2 (C) and H3K27TM (D) in the ACC of the Sham and NeuP groups after GSK126 treatment. E–G ELISA analysis of IL-1β (E), TNF-α (F), and IL-6 (G) expression levels in the ACC of the Sham and NeuP groups after GSK126 treatment from day 3 to day 14 post-surgery. H, I Relative expression of LC3II (H) and p62 protein (I) in the ACC of the Sham and NeuP groups after GSK126 treatment from day 3 to day 14 post-surgery. For C–I: mean ± SD; n = 8; n.s., no significant difference; *P < 0.05, **P < 0.01, ***P < 0.001 vs DMSO group.